New Approaches for Studying Alcoholic Liver Disease

[1]  M. Karin,et al.  Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. , 2014, Cell metabolism.

[2]  Y. Inagaki,et al.  Mechanisms of action of acetaldehyde in the up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. , 2014, The American journal of pathology.

[3]  H. Zhao,et al.  Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway , 2014, PloS one.

[4]  L. J. Lee,et al.  Epigenetic regulation of connective tissue growth factor by MicroRNA‐214 delivery in exosomes from mouse or human hepatic stellate cells , 2014, Hepatology.

[5]  B. Cronstein,et al.  Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3 , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  S. Glaser,et al.  The functional role of microRNAs in alcoholic liver injury , 2014, Journal of cellular and molecular medicine.

[7]  Kristen Jepsen,et al.  Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.

[8]  B. Ryffel,et al.  IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation , 2013, The Journal of Immunology.

[9]  B. Cronstein,et al.  Adenosine A2A receptors promote collagen production by a Fli1- and CTGF-mediated mechanism , 2013, Arthritis Research & Therapy.

[10]  M. Soresi,et al.  Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[11]  B. Gao,et al.  Mouse model of chronic and binge ethanol feeding (the NIAAA model) , 2013, Nature Protocols.

[12]  I. McKillop,et al.  Rodent models of alcoholic liver disease: of mice and men. , 2012, Alcohol.

[13]  P. Kubes,et al.  Sterile inflammation in the liver. , 2012, Gastroenterology.

[14]  A. Dhanda,et al.  Molecular targets in the treatment of alcoholic hepatitis. , 2012, World journal of gastroenterology.

[15]  J. Kolls,et al.  Targeting IL-17 and TH17 cells in chronic inflammation , 2012, Nature Reviews Drug Discovery.

[16]  R. Schwabe,et al.  Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. , 2012, Gastroenterology.

[17]  K. Iwaisako,et al.  Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. , 2012, Gastroenterology.

[18]  B. Gao,et al.  Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice , 2012, Hepatology.

[19]  B. Gao,et al.  STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. , 2012, Journal of hepatology.

[20]  B. Gao,et al.  Inflammation in alcoholic liver disease. , 2012, Annual review of nutrition.

[21]  S. Dooley,et al.  Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. , 2012, Gastroenterology.

[22]  D. Brigstock,et al.  Regulation of hepatic stellate cells by connective tissue growth factor. , 2012, Frontiers in bioscience.

[23]  Christopher K. Glass,et al.  Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis , 2012, Proceedings of the National Academy of Sciences.

[24]  B. Schnabl,et al.  Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. , 2012, World journal of hepatology.

[25]  Fanyin Meng,et al.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. , 2012, Translational gastrointestinal cancer.

[26]  Clay C C Wang,et al.  Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator‐activated receptor γ in hepatic stellate cells for their antifibrotic effect , 2012, Hepatology.

[27]  I. McKillop,et al.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. , 2012, Alcoholism, clinical and experimental research.

[28]  S. Friedman,et al.  Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. , 2012, Gastroenterology.

[29]  K. Machida,et al.  Mouse intragastric infusion (iG) model , 2012, Nature Protocols.

[30]  K. Machida,et al.  Morphogens and hepatic stellate cell fate regulation in chronic liver disease , 2012, Journal of gastroenterology and hepatology.

[31]  A. Chien,et al.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. , 2012, Gastroenterology.

[32]  Q. Gao,et al.  IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma , 2011, Molecular Cancer.

[33]  R. Bataller,et al.  Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.

[34]  D. Franchimont,et al.  Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. , 2011, Journal of hepatology.

[35]  Xuehao Wang,et al.  Interleukin‐22 promotes human hepatocellular carcinoma by activation of STAT3 , 2011, Hepatology.

[36]  Zhaoli Sun,et al.  Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. , 2011, The American journal of pathology.

[37]  J. Luk,et al.  Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression , 2011, PloS one.

[38]  H. Tsukamoto,et al.  Epigenetic cell fate regulation of hepatic stellate cells , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[39]  S. Dooley,et al.  In vivo consequences of liver‐specific interleukin‐22 expression in mice: Implications for human liver disease progression , 2011, Hepatology.

[40]  G. Landeira,et al.  Risk factors for infection in chronic hepatitis C: A high prevalence of sexual exposure among human immunodeficiency virus–coinfected women , 2011, Hepatology.

[41]  T. Han,et al.  Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. , 2011, Cancer cell.

[42]  K. Kodys,et al.  Hepatocyte‐specific hypoxia‐inducible factor‐1α is a determinant of lipid accumulation and liver injury in alcohol‐induced steatosis in mice , 2011, Hepatology.

[43]  W. Jeong,et al.  Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. , 2011, Alcoholism, clinical and experimental research.

[44]  B. Gao,et al.  Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target , 2011, International journal of biological sciences.

[45]  D. Brenner,et al.  Innate immunity in alcoholic liver disease. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[46]  N. Hayashi,et al.  Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice. , 2011, Biochemical and biophysical research communications.

[47]  Yoichiro Iwakura,et al.  Review Functional Specialization of Interleukin-17 Family Members , 2022 .

[48]  A. Dolganiuc,et al.  Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells , 2011, Hepatology.

[49]  H. Volk,et al.  Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa , 2011, The Journal of Immunology.

[50]  Manolito Torralba,et al.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.

[51]  F. Tacke,et al.  Role of IL-17 and Th17 Cells in Liver Diseases , 2010, Clinical & developmental immunology.

[52]  K. Kodys,et al.  Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease* , 2010, The Journal of Biological Chemistry.

[53]  Defeng Wu,et al.  CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells. , 2010, Biochemical and biophysical research communications.

[54]  D. Thabut,et al.  Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? , 2010, Journal of hepatology.

[55]  R. Bataller,et al.  Interleukin‐22 treatment ameliorates alcoholic liver injury in a murine model of chronic‐binge ethanol feeding: Role of signal transducer and activator of transcription 3 , 2010, Hepatology.

[56]  M. Pirisi,et al.  Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. , 2010, Human immunology.

[57]  A. Stavitsky,et al.  Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. , 2010, Gastroenterology.

[58]  Darjus F. Tschaharganeh,et al.  Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis. , 2010, The American journal of pathology.

[59]  Xin-Yuan Fu,et al.  Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell–specific signal transducer and activator of transcription 3 gene knockout mice , 2010, Hepatology.

[60]  Michael Krawczak,et al.  Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians , 2010, Hepatology.

[61]  Xin-Yuan Fu,et al.  Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity , 2010, Hepatology.

[62]  B. Gao,et al.  Th17 cells and their associated cytokines in liver diseases , 2010, Cellular and Molecular Immunology.

[63]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[64]  T. Wynn,et al.  Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.

[65]  Zheng Shen,et al.  Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[66]  E. Quinlivan,et al.  Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol‐fed cystathionine beta synthase–deficient mouse , 2010, Hepatology.

[67]  H. Tsukamoto,et al.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. , 2010, Gastroenterology.

[68]  Darjus F. Tschaharganeh,et al.  Lack of interleukin‐6/glycoprotein 130/signal transducers and activators of transcription‐3 signaling in hepatocytes predisposes to liver steatosis and injury in mice , 2010, Hepatology.

[69]  G. Szabo,et al.  Emerging role of microRNAs in liver diseases. , 2009, World journal of gastroenterology.

[70]  W. Naugler.  Erratum: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production (Science (2007) (121)) , 2009 .

[71]  Y. Iwakura,et al.  Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection1 , 2009, The Journal of Immunology.

[72]  Xin-Yuan Fu,et al.  Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. , 2009, Gastroenterology.

[73]  D. Pinato,et al.  Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease , 2009, Oncology.

[74]  M. Karin.  NF-kappaB as a critical link between inflammation and cancer. , 2009, Cold Spring Harbor perspectives in biology.

[75]  A. Mortazavi,et al.  Computation for ChIP-seq and RNA-seq studies , 2009, Nature Methods.

[76]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[77]  P. Park.  ChIP–seq: advantages and challenges of a maturing technology , 2009, Nature Reviews Genetics.

[78]  A. Dolganiuc,et al.  MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. , 2009, Alcoholism, clinical and experimental research.

[79]  S. Gaffen.  Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.

[80]  B. Gao,et al.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases , 2009, Journal of leukocyte biology.

[81]  Min You,et al.  Adiponectin: A Key Adipokine in Alcoholic Fatty Liver , 2009, Experimental biology and medicine.

[82]  R. Rao.  Endotoxemia and gut barrier dysfunction in alcoholic liver disease , 2009, Hepatology.

[83]  R. Bataller,et al.  Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. , 2009, Gastroenterology.

[84]  Jian-Min Yuan,et al.  Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. , 2009, Carcinogenesis.

[85]  I. McKillop,et al.  Role of alcohol in liver carcinogenesis. , 2009, Seminars in liver disease.

[86]  H. Spits,et al.  Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? , 2009, Nature Reviews Immunology.

[87]  T. Donohue.  Autophagy and ethanol-induced liver injury. , 2009, World journal of gastroenterology.

[88]  L. Chiriboga,et al.  Amendment history : Corrigendum ( April 2009 ) Adenosine signaling contributes to ethanol-induced fatty liver in mice , 2018 .

[89]  R. Ray,et al.  Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog , 2009, Proceedings of the National Academy of Sciences.

[90]  J. Devière,et al.  The interleukin‐17 pathway is involved in human alcoholic liver disease , 2009, Hepatology.

[91]  G. Arteel,et al.  PKCepsilon plays a causal role in acute ethanol-induced steatosis. , 2009, Archives of biochemistry and biophysics.

[92]  C. Tato,et al.  Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22 , 2009, The Journal of experimental medicine.

[93]  J. Reiser,et al.  TRIF and IRF-3 Binding to the TNF Promoter Results in Macrophage TNF Dysregulation and Steatosis Induced by Chronic Ethanol1 , 2008, The Journal of Immunology.

[94]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[95]  Shelly C. Lu,et al.  Methionine metabolism and liver disease. , 2008, Annual review of nutrition.

[96]  L. Chiriboga,et al.  Ecto-5′-Nucleotidase (Cd73)-Mediated Extracellular Adenosine Production Plays a Critical Role in Hepatic Fibrosis , 2008, Nucleosides, nucleotides & nucleic acids.

[97]  L. Chiriboga,et al.  Ecto‐5′‐nucleotidase (CD73) ‐mediated extracellular adenosine production plays a critical role in hepatic fibrosis , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  D. Brenner,et al.  Toll‐like receptors and adaptor molecules in liver disease: Update , 2008, Hepatology.

[99]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[100]  Min You,et al.  Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[101]  R. Wells.  The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[102]  Xin-Yuan Fu,et al.  Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. , 2008, Gastroenterology.

[103]  G. Marsicano,et al.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. , 2008, Cell metabolism.

[104]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[105]  S. Gaffen,et al.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. , 2008, Cytokine.

[106]  T. Mello,et al.  Alcohol induced hepatic fibrosis: role of acetaldehyde. , 2008, Molecular aspects of medicine.

[107]  Li Juan Zhang,et al.  Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. , 2008, Alcoholism, clinical and experimental research.

[108]  R. Beyer,et al.  Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. , 2008, The Journal of experimental medicine.

[109]  Chen Dong,et al.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.

[110]  B. Cronstein,et al.  Adenosine A2A Receptor Occupancy Stimulates Collagen Expression by Hepatic Stellate Cells via Pathways Involving Protein Kinase A, Src, and Extracellular Signal-Regulated Kinases 1/2 Signaling Cascade or p38 Mitogen-Activated Protein Kinase Signaling Pathway , 2007, Molecular Pharmacology.

[111]  S. Akira,et al.  Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice , 2007, Hepatology.

[112]  A. Murphy,et al.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.

[113]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[114]  A. Stavitsky,et al.  Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. , 2007, Gastroenterology.

[115]  P. Murray.  STAT3-mediated anti-inflammatory signalling. , 2006, Biochemical Society transactions.

[116]  W. Alexander,et al.  General Nature of the STAT3-Activated Anti-Inflammatory Response1 , 2006, The Journal of Immunology.

[117]  N. Kaplowitz,et al.  Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. , 2006, Journal of hepatology.

[118]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[119]  Xiong-Zhi Wu,et al.  Origin of hepatocellular carcinoma: Role of stem cells , 2006, Journal of gastroenterology and hepatology.

[120]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[121]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[122]  J. Sicklick,et al.  Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. , 2006, Carcinogenesis.

[123]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[124]  H. Tsukamoto.  Fat paradox in liver disease. , 2005, The Keio journal of medicine.

[125]  H. Tsukamoto.  Adipogenic phenotype of hepatic stellate cells. , 2005, Alcoholism, clinical and experimental research.

[126]  H. Fukui.  Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. , 2005, Alcoholism, clinical and experimental research.

[127]  Y. Inagaki,et al.  Early response of α2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF‐β independent , 2005 .

[128]  Junitsu Ito,et al.  NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells , 2005, Hepatology.

[129]  C. Croniger,et al.  Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. , 2005, Gastroenterology.

[130]  B. Gao,et al.  Cytokines, STATs and liver disease. , 2005, Cellular & molecular immunology.

[131]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[132]  H. Tsukamoto,et al.  Adipogenic Transcriptional Regulation of Hepatic Stellate Cells* , 2005, Journal of Biological Chemistry.

[133]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[134]  D. Crabb,et al.  The role of AMP-activated protein kinase in the action of ethanol in the liver. , 2004, Gastroenterology.

[135]  T. Morgan,et al.  Alcohol and hepatocellular carcinoma. , 2004, Gastroenterology.

[136]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[137]  B. Gao,et al.  Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. , 2004, Alcohol.

[138]  N. Kaplowitz,et al.  Role of TNF‐α in ethanol‐induced hyperhomocysteinemia and murine alcoholic liver injury , 2004 .

[139]  D. Vergani,et al.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. , 2004, Journal of hepatology.

[140]  W. Zong,et al.  Alkylating DNA damage stimulates a regulated form of necrotic cell death. , 2004, Genes & development.

[141]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[142]  R. Rippe,et al.  Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells* , 2004, Journal of Biological Chemistry.

[143]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[144]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[145]  L. Gilbertson,et al.  Cre-lox recombination: Cre-ative tools for plant biotechnology. , 2003, Trends in biotechnology.

[146]  G. Arteel,et al.  Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. , 2003, Gastroenterology.

[147]  J. Iredale,et al.  Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[148]  C. Naus,et al.  Proposal for a unified CCN nomenclature , 2003, Molecular pathology : MP.

[149]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[150]  Z. Tian,et al.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. , 2002, The Journal of clinical investigation.

[151]  Diane Lejeune,et al.  Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line , 2002, The Journal of Biological Chemistry.

[152]  A. Andoh,et al.  IL-17 Selectively Down-Regulates TNF-α-Induced RANTES Gene Expression in Human Colonic Subepithelial Myofibroblasts1 , 2002, The Journal of Immunology.

[153]  D. Crabb,et al.  Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)* , 2002, The Journal of Biological Chemistry.

[154]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[155]  Katie Chan,et al.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[156]  S. Bhattacharya,et al.  Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.

[157]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[158]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[159]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[160]  S. Müller,et al.  The double life of HMGB1 chromatin protein: architectural factor and extracellular signal , 2001 .

[161]  G. Gores,et al.  Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. , 2001, Journal of hepatology.

[162]  S. Pestka,et al.  Identification of the Functional Interleukin-22 (IL-22) Receptor Complex , 2001, The Journal of Biological Chemistry.

[163]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[164]  K. Hoppo,et al.  Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. , 2000, Alcoholism, clinical and experimental research.

[165]  S. Adunyah,et al.  Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. , 1999, Biochemical and biophysical research communications.

[166]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[167]  D. Brenner,et al.  The role of gut‐derived bacterial toxins and free radicals in alcohol‐induced liver injury , 1998, Journal of gastroenterology and hepatology.

[168]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[169]  A. Diehl.  Alcoholic liver disease: natural history. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[170]  F. Capron,et al.  Excess weight risk factor for alcoholic liver disease , 1997, Hepatology.

[171]  N. Sheron,et al.  Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis , 1996, Hepatology.

[172]  S. Sell,et al.  Is there a liver stem cell? , 1990, Cancer research.

[173]  K. Kidd,et al.  The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. , 1988, Genomics.

[174]  S. Friedman,et al.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[175]  C. Glass,et al.  Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. , 2012, Current topics in microbiology and immunology.

[176]  Yi Shen,et al.  Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. , 2012, Frontiers in bioscience.

[177]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[178]  H. Spits,et al.  Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cells , 2009, Nature Immunology.

[179]  Yu-Chen Fan,et al.  Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B , 2009, Journal of Clinical Immunology.

[180]  T. Morgan,et al.  Alcoholic hepatitis. , 2009, The New England journal of medicine.

[181]  S. Schinner,et al.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice , 2009 .

[182]  Steven Henikoff,et al.  Nucleosome destabilization in the epigenetic regulation of gene expression , 2008, Nature Reviews Genetics.

[183]  L. Steinman.  Erratum: A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[184]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[185]  M. Alison.  Liver stem cells , 2007, Stem Cell Reviews.

[186]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[187]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[188]  R. D. Hatton,et al.  Transforming growth factor-beta induces development of the T(H)17 lineage. , 2006, Nature.

[189]  R. Bataller,et al.  Amendment history : Corrigendum ( April 2005 ) Liver fibrosis Ramón Bataller , 2018 .

[190]  L. Gierl,et al.  Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. , 2005, Journal of cellular and molecular medicine.

[191]  Y. Inagaki,et al.  Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. , 2005, Hepatology.

[192]  N. Kaplowitz,et al.  Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. , 2004, Hepatology.

[193]  R. Rippe,et al.  Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. , 2004, The Journal of biological chemistry.

[194]  H. Flynn.  Comparison of cross-sectional and daily reports in studying the relationship between depression and use of alcohol in response to stress in college students. , 2000, Alcoholism, clinical and experimental research.

[195]  M. Seldin,et al.  Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. , 1995, Immunity.